IFNA1 and hepatitis C virus infection: This accounts for the clinical use of IFNs for various diseases, such as multiple sclerosis or hepatitis C. Among the three known receptor-specific IFN subtypes, type I IFNs (IFN-α and IFN-β) are prominent as the first antiviral reaction to infection.